25 Aug 2017
Kate: I’m making a difference
Kate’s mother died of acute myloid leukaemia at the age of 34, leaving behind four young children. When Kate reached the same age, she took up running and began to raise money for our cause
My mum died after a short battle with acute myeloid leukaemia. She was 34 and left four children behind – I was eight years old.
I started running nearly three years ago, the year I turned 34. I started with 10k a month for a year, building up to half marathons last year.
I’ve always watched the London Marathon in awe, thinking I would love to do it but never thought it possible. I chose to run it for Leukaemia UK because I wanted to find a leukaemia charity that was relatively local, so that by raising money I would make a difference.
Kate completed the Great North Run and the Great South Run for Leukaemia UK in 2016, then the London Marathon and the Royal Parks Half Marathon in 2017. She raised more than £3,000 for Leukaemia UK – what an inspiration!
We are delighted that Kate has chosen to support us in memory of her mother and are so impressed with her dedication and determination. Thank you!
Read more stories from our community.
Related posts
9 January 2018
Blood cancer and your emotions – an expert’s insight
Specialist blood cancer counsellor Philip Alexander explains why talking therapies can form a crucial part of treatment
1 August 2022
One Cancer Voice writes to Sajid Javid ahead of 10-Year Cancer Plan
Today, with over 50 cancer charities, we wrote to the Secretary of State for Health & Social Care, Sajid Javid, to set out our expectation for next month’s 10-Year Cancer Plan….
25 August 2022
Leukaemia Care and Leukaemia UK join forces with funky feathered friend to make disease symptoms more memorable
The two leading UK leukaemia charities have launched a collaboration today with a difference. They’ve joined forces with a blue and gold Macaw parrot called Henry to create an original…
10 January 2023
Clinical trial begins for pioneering new cancer treatment
Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia.